Welcome to Broadline Capital
Founded 18 years ago, Broadline Capital is a global alternative investment firm focused primarily on growth capital and purpose-driven investments in North America and Asia. At Broadline, we're inspired by champions — people of vision and courage — whose ideas can positively change the world, and who are ready to transform their ideas into the next industry-changing company.
When evaluating opportunities, we seek companies that are positioned to thrive as the world continues to transition toward an economy increasingly driven by the pursuit of healthier living and a more efficient, purposeful, and sustainable way of life. We seek category leaders and category creators that are reshaping their industry, and prefer highly-charged sectors where innovation, growth, high margins, and market consolidation are creating abundant opportunities. Successful candidates are led by management teams who demonstrate the credibility and readiness to capture the full opportunity of Broadline's established platform, access to expertise, and vast network of relationships built over many years.
Broadline's principals and venture partners have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in their categories. Their collective experience and relationships combine to benefit Broadline-supported companies as they develop to the next level. We believe Broadline’s current opportunities are among the most exciting on the planet.
New York | Miami | San Diego | Boulder | Columbus | Seoul | Shanghai | Hong Kong | London
Broadline's proprietary investment process is designed to stretch alpha at every link of the investment value chain. We seek diversification across a range of industries, geographies, transaction structures, development stages, and market capitalizations. When selecting opportunities, Broadline takes a two-pronged approach:
First, we start with a "Top-Down" view to identify thematic categories where an abundance of companies are positioned to grow and create broad impact as the world continues to transition toward an economy increasingly driven by the pursuit of healthier living and a more efficient and sustainable way of life.
Next, we take a "Bottom-Up" view to identify rising category leaders and category creators that have potential to reshape their industry and whose management teams display credibility and readiness to benefit from Broadline's support.
We place emphasis on the following core thematic areas:
Purpose-driven Technologies. Creative business models based on differentiated technologies and products are creating new asset classes and enabling a more efficient way of life.
Sustainability & Environment. Innovations in Cleantech and Energy Storage Solutions are accelerating the Electrification of Everything.
Health & Life Sciences. Promising innovations in Biotech, Pharma, and Medical Technology are disrupting the way medicine is practiced to improve Patient Outcomes.
Financial Services. Innovations in Digital Finance are Unlocking Value by creating New Asset Classes and introducing Smarter, More Accessible, Higher-Value, and Decentralized Financial Products and Services.
Food System. Innovations in Food Safety, Traceability, and Sustainable Agriculture are enabling More Resilient, Sustainable, and Smarter Agri-Business Supply Chains and Delivery Solutions.
We invite you to scroll through selected case examples below. If you are a Broadline registered investor, please click on the "Investor Login" tab at the top of this website for reports from Broadline-supported companies or to review current opportunities from our curated pipeline.
Health & Life Sciences
Less-INVASIVE Medical Devices
EndoSphere is a medical technology company that has developed a first-in-class, less-invasive medical device platform to treat metabolic diseases, including some of the world's largest healthcare issues such as Obesity, Type 2 Diabetes, and Fatty Liver Disease. EndoSphere's novel "Endo-Metabolic" device platform represents a completely new category of devices that is the first to uniquely focus on the Duodenum, the upper intestinal organ that is widely recognized as the body's metabolic control center. Endosphere's flagship anti-obesity device is incisionless, reversible and repeatable. In clinical studies, the device enabled Obese patients to achieve significant Excess Weight Loss (EWL) without the need for more invasive alternatives. Unlike restrictive devices and bariatric surgeries, which typically work against nature, EndoSphere's "Endo-Metabolic" devices work with the body by amplifying its physiological responses to food intake in order to help accelerate satiation, recalibrate brain-gut metabolic feedback loops, recalibrate hormones, and rebalance insulin levels. EndoSphere's patent asset portfolio is 100% company-owned and free from any third-party licensing or royalty obligations. EndoSphere has received numerous industry recognitions, including the industry's "Fierce15" award, named by FierceBiotech, which annually recognizes the world's most promising privately-held medical innovations. The original version of its anti-obesity device received CE Mark (regulatory approval in 31 countries), and an enhanced version has entered clinical stages of development.
Sustainability & Environment
Carbon-Free Lithium-ion and
Solid State BatterY CATHODES
Powermers has developed the world's first Carbon-Free Cathodes for Lithium-ion and Solid State Batteries. They did it by replacing the "inactive/deadweight" material in conventional cathodes (the Carbon and Binders) with proprietary conductive nano-scale polymer materials. Powermers' transition-metal polymers demonstrate higher catalytic functionality than pure noble-metal catalysts (including gold, platinum, and palladium). Powermers' resulting performance differentiates it through both safety and energy storage capacity, as documented in the industry's peer-reviewed publications including American Chemical Society's Applied Materials & Interfaces. Powermers' technology has been independently-validated by the U.S. Army Corps of Engineers (C.E.R.L.) and universities around the world including the Center for Automotive Research at The Ohio State University (O.S.U. C.A.R.), demonstrating measurable advantages:
Safer & More Stable: Powermers' technology dramatically reduces the battery's Thermal Runaway Risk, the primary cause of high-voltage lithium-ion battery combustion.
Higher Energy: Powermers' technology expands the battery's Active Material Limit, thereby increasing Energy without sacrificing Power, Cycle Life, Weight, or Cost per KWH.
Ease of Adoption: Powermers' technology can readily be adopted by existing battery manufacturers without changing their fundamental processes
Cost per KWH & Reduced Toxicity: Powermers' technology also enables battery manufacturers to capture savings in total cost per KWH by reducing the usage of costly (and toxic) solvents.
Our investment leaders are past CEOs and entrepreneurs who have previously led companies where they created significant value and negotiated quality exits for themselves and their investors. Team members have backgrounds at recognized institutions and top educational programs. They have spent their entire careers building trust-based relationships globally, and have led some of the most creative deals in the history of their respective categories. They understand what it takes to align stakeholders with a shared vision and develop a successful business, because they've done it. Staying close to their roots as company operators, they love collaborating with inspired management teams and working together toward realizing a shared vision.
"At Broadline Capital, we are inspired by champions – people of vision and courage – whose ideas can positively change the world, and who are ready to transform their ideas into the next industry-changing company. If you share our perspective, we invite you to join us. We look forward to hearing from you."
MIAMI: 80 SW 8th St., 20th Floor, Miami, FL 33130
MANHATTAN: 1 Rockefeller Plaza, 11th Floor, New York, NY 10020
Broadline® is a Registered Trademark.
Copyright © Broadline Capital 2004-2022.
All Rights Reserved.